Lewy body dementia research is underway in Stanford’s Poston Lab with the appointment of Dr. Joseph Winer as the Sue Berghoff LBD Research Fellow. We established this research fellowship in honor of our co-founder, Sue Berghoff, who has Lewy body dementia (LBD).
Lewy body disease is among the three leading causes of progressive dementia, along with Alzheimer’s and vascular diseases. Over time, it may present as either Dementia with Lewy bodies (DLB) or as Parkinson’s disease dementia (PDD). Neuroscience advances bring improved understanding of the complex syndrome that is dementia, and LBD research has a central role in this effort.
As the Sue Berghoff LBD Research Fellow, Dr. Winer is focused on developing novel markers of Lewy body dementia. His work explores the relationships between data from four research areas: cognitive and behavioral assessments, brain imaging, blood and cerebrospinal fluid samples, and sleep-wake actigraphy measures.
We are grateful to Stanford Medicine for its sustained commitment and integrated approach to dementia research, from bench to bedside.
Poston Lab, led by Dr. Kathleen Poston, leverages Stanford’s research infrastructure for in-depth clinical, biological, and imaging data on people with Lewy body, Parkinson’s and Alzheimer’s diseases, and older adults with no neurological problems.